This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Dornase Alfa Inhalation Solution

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Dornase Alfa Inhalation Solution Means

Dornase alfa inhalation solution is a medicine that contains an enzyme designed to break down DNA found in thick mucus. This action helps make the mucus thinner and less sticky, which can improve the ability to clear mucus from the lungs. It is most commonly used as a treatment for cystic fibrosis, a genetic condition where thick mucus builds up in the lungs and digestive system, causing breathing difficulties and repeated infections. Dornase alfa is given as a mist that patients inhale into their lungs.

Why Dornase Alfa Can Matter in Cancer Care

While dornase alfa is mainly used for cystic fibrosis, it is also being studied for other uses in cancer care. For example, it may help reduce the thickness of saliva in patients undergoing treatment for head and neck cancers. Thick saliva can cause discomfort and make swallowing or speaking difficult. Research is ongoing to understand how dornase alfa might support symptom management in these cases.

What Patients Might See or Hear About Dornase Alfa

Patients and caregivers may come across the term dornase alfa inhalation solution or its brand name, Pulmozyme, in medical reports, treatment plans, or educational materials. It is important to understand that seeing this term does not automatically mean a diagnosis of cystic fibrosis or a specific treatment plan. Instead, it is a medicine that may be part of managing lung or saliva-related symptoms. Patients should ask their care team how this medicine relates to their individual health situation.

Common Sources of Confusion

Dornase alfa may appear under different names, such as Pulmozyme, which can cause confusion. Also, because it is mainly known for treating cystic fibrosis, seeing it mentioned in other contexts—like cancer care—might be unclear. It’s important not to assume the presence of this medicine means a diagnosis of cystic fibrosis or a particular treatment without clarification from healthcare providers.

How to Use This Information Safely

This information is meant to help patients and caregivers understand what dornase alfa inhalation solution is and how it might be used. It does not replace medical advice or decisions about treatment. If you see this term in your medical records or hear it mentioned, the best step is to ask your healthcare team what it means for your care. They can explain why it is being used and how it fits into your treatment plan.

Next Steps for Patients and Caregivers

If you or a loved one is prescribed dornase alfa inhalation solution or you see it mentioned in your care, talk with your healthcare providers about its purpose, benefits, and any questions you have. Understanding how this medicine works and why it is part of your care can help you feel more confident and involved in your treatment decisions.

Sources

Public source information used for this glossary entry includes: